NCT06758960 is a clinical trial in HELLP Syndrome, sponsored by CHU Mohammed VI Marrakech.

Who is sponsoring NCT06758960?

NCT06758960 is sponsored by CHU Mohammed VI Marrakech.

What condition does NCT06758960 study?

NCT06758960 studies HELLP Syndrome, Preeclampsia.

Is NCT06758960 still recruiting?

NCT06758960 is currently completed. Last updated 31 March 2026.

Last reviewed 2026-03-31 · How we verify

NCT06758960

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Analysis of Biological Progression and Regression of HELLP Syndrome in Time

Completed Last updated 31 March 2026

What this trial tests

trial in HELLP Syndrome in 72 participants. Completed in 31 August 2025.

Timeline

1 July 2023

Primary endpoint
31 July 2025

31 August 2025

Quick facts

Lead sponsor	CHU Mohammed VI Marrakech
Status	Completed
Study type	OBSERVATIONAL
Enrollment	72
Start date	1 July 2023
Primary completion	31 July 2025
Estimated completion	31 August 2025
Sites	1 location across Morocco

Conditions studied

HELLP Syndrome — all drugs for HELLP Syndrome →
Preeclampsia — all drugs for Preeclampsia →

Sponsor

CHU Mohammed VI Marrakech

Who can join

Eligibility, female only, with HELLP Syndrome or Preeclampsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective observational study about progression and regression of biological parameters of HELLP syndrome

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other CHU Mohammed VI Marrakech trials

Trials by the same sponsor.

NCT06357637 — Abdominal Circumference Measure in Caesarian Section · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06758960 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CHU Mohammed VI Marrakech
Last refreshed: 31 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06758960.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing